Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
Clinical trial NCT00458601 · COMPLETED
Trial details
- NCT number
- NCT00458601
- Sponsor
- Celldex Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2010-11-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.